Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Q Eichacker

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Mens Sana Monographs|October 21, 2011
Medical guidelines and performance measures: the need to keep them free of industry influencePeter Q Eichacker, Charles Natanson
Intensive Care Medicine|February 28, 2007
Increasing evidence that the risks of rhAPC may outweigh its benefitsPeter Q Eichacker, Charles Natanson
Critical Care Medicine|January 25, 2003
Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trialsPeter Q Eichacker, Charles Natanson
Intensive Care Medicine|August 25, 2010
Evaluating guidelines for critical care: a need for detailPeter Q Eichacker, Charles Natanson
Annals of Internal Medicine|August 18, 2015
ACP Journal Club: in early septic shock, early goal-directed therapy did not reduce 90-day mortalityDharmvir S Jaswal, Peter Q Eichacker
Critical Care Medicine|September 28, 2002
Prophylactic granulocyte colony-stimulating factor in the critically ill: carefully balancing the benefits and risksZenaide M N Quezado, Peter Q Eichacker
Critical Care Medicine|November 29, 2007
Separating practice guidelines from pharmaceutical marketingPeter Q Eichacker, Charles Natanson, Robert L Danner
Critical Care Medicine|December 30, 2008
Recombinant human activated protein C, package labeling, and hemorrhage risksDaniel A Sweeney, Charles Natanson, Peter Q Eichacker
Critical Care Medicine|March 25, 2020
Sepsis Bundles That Focus on Clinician Judgment and Proven Interventions Are Needed to Increase Bundle Compliance and EffectivenessJeffrey R Strich, Jeffrey Wang, Peter Q Eichacker
Current Infectious Disease Reports|August 31, 2013
The Surviving Sepsis Campaign's Revised Sepsis BundlesAmisha V Barochia, Xizhong Cui, Peter Q Eichacker
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Mens Sana Monographs|October 21, 2011
Medical guidelines and performance measures: the need to keep them free of industry influencePeter Q Eichacker, Charles Natanson
Intensive Care Medicine|February 28, 2007
Increasing evidence that the risks of rhAPC may outweigh its benefitsPeter Q Eichacker, Charles Natanson
Critical Care Medicine|January 25, 2003
Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trialsPeter Q Eichacker, Charles Natanson
Intensive Care Medicine|August 25, 2010
Evaluating guidelines for critical care: a need for detailPeter Q Eichacker, Charles Natanson
Annals of Internal Medicine|August 18, 2015
ACP Journal Club: in early septic shock, early goal-directed therapy did not reduce 90-day mortalityDharmvir S Jaswal, Peter Q Eichacker
Critical Care Medicine|September 28, 2002
Prophylactic granulocyte colony-stimulating factor in the critically ill: carefully balancing the benefits and risksZenaide M N Quezado, Peter Q Eichacker
Critical Care Medicine|November 29, 2007
Separating practice guidelines from pharmaceutical marketingPeter Q Eichacker, Charles Natanson, Robert L Danner
Critical Care Medicine|December 30, 2008
Recombinant human activated protein C, package labeling, and hemorrhage risksDaniel A Sweeney, Charles Natanson, Peter Q Eichacker
Critical Care Medicine|March 25, 2020
Sepsis Bundles That Focus on Clinician Judgment and Proven Interventions Are Needed to Increase Bundle Compliance and EffectivenessJeffrey R Strich, Jeffrey Wang, Peter Q Eichacker
Current Infectious Disease Reports|August 31, 2013
The Surviving Sepsis Campaign's Revised Sepsis BundlesAmisha V Barochia, Xizhong Cui, Peter Q Eichacker
Pageof 13